[Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].

Octreotide: a long-acting somatostatin analog.

Treatment of small intestinal fistulas with octreotide, a somatostatin analog.

Cardiovascular effects of the somatostatin analog octreotide in acromegaly.

Endocrine applications of the somatostatin analogue octreotide (Sandostatin).

Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors.

Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog.

Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation.

[Enteral hyperoxalosis due to therapy with a somatostatin analog].

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.

Effect of small doses of somatostatin analog, octreotide, on gallbladder contractility in normal Chinese adults.

Somatostatin-receptor imaging in the localization of endocrine tumors.

Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy.

Somatostatin and octreotide in gastroenterology.

[Endocrine tumors and their therapy].

Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).

Metastatic insulinoma managed with radiolabeled somatostatin analog.

Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors.

Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.

Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome.

In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.

Somatostatin analog withdrawal in patients with acromegaly: an elusive goal?

Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.

Short term treatment of acromegaly with the somatostatin analog octreotide: the first double-blind randomized placebo-controlled study on its effects.

Suggest Documents

Octreotide: a long-acting somatostatin analog.

Treatment of small intestinal fistulas with octreotide, a somatostatin analog.

Cardiovascular effects of the somatostatin analog octreotide in acromegaly.

Endocrine applications of the somatostatin analogue octreotide (Sandostatin).

Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors.

Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog.

Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation.

[Enteral hyperoxalosis due to therapy with a somatostatin analog].

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.

Effect of small doses of somatostatin analog, octreotide, on gallbladder contractility in normal Chinese adults.

Somatostatin-receptor imaging in the localization of endocrine tumors.

Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy.

Somatostatin and octreotide in gastroenterology.

[Endocrine tumors and their therapy].

Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).

Metastatic insulinoma managed with radiolabeled somatostatin analog.

Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors.

Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.

Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome.

In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.

Somatostatin analog withdrawal in patients with acromegaly: an elusive goal?

Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.

Short term treatment of acromegaly with the somatostatin analog octreotide: the first double-blind randomized placebo-controlled study on its effects.

[Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].

Recommend Documents

Follow Us